Home Business

Caretel bags GSM call centre contract from MTNL

BPO services provider Caretel, a Dalmia group company, has bagged a two-year contract from state-owned Mahanagar Telephone Nigam Ltd (MTNL) to manage the latter’s call centre. The financial terms of the deal were not disclosed. - "275 mn 3G subscribers in India by 2013" - Shuchi Bansal: MyWay or the highway">Shuchi Bansal: MyWay or the highway - 275 mn 3G subscribers in India by "13: Evalueserve - Pre-bid meet on 3G spectrum auction likely on Oct 10/12 - MTNL pares gain, ends flat - BSNL, MTNL in consortium to buy 46% in Kuwait telecom firm The contract is for an initial 200 seats, and this will help MTNL to save costs and increase profitability, Caretel said in a release issued here today. Under the deal, Caretel will manage in-bound call centre operations for MTNL’s GSM services in Mumbai, and offer multi-lingual voice and data support through its call centre. The Dalmia group company will also provide billing support, outbound calling for lead generation, telemarketing and billing reminders for MTNL’s subscribers. “We see great potential business in the Indian telecom market in coming days and would continue adding more names to the growing list of our clients around the country,” Caretel Infotech CEO Amit Roy said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Toshiba completes pilot plant for CO2 capture technology
Toshiba Corp has said it has started test operating a pilot plant to develop a commercially viable technology to separate and capture carbon dioxide from flue gas generated in the process of thermal power generation.
Popular Articles
fast payday loans

Mumbai attacks may cost insurers Rs 500 cr
Insurance claims arising out of the Mumbai terror attacks in 2008 are estimated to wipe out about Rs 500 crore from the corpus set up by general insurers to fund such losses.

HC stops Zydus drug sale on Sun petition
The Madras High Court today directed Ahmedabad-based Zydus Cadila (Cadila Healthcare) not to sell its anti-depressant drug, Venz (venlafaxine), in the domestic market for the time being, based on a trademark complaint from Mumbai-based Sun Pharmaceutical industries.